BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Regenicin, Inc. (RGIN.OB) Announces Advanced Discussions With Developers to Establish New Facilities in Florida


6/9/2011 9:01:14 AM

LITTLE FALLS, NJ--(Marketwire - June 08, 2011) -

Regenicin, Inc. (OTCBB: RGIN) announces it is in advanced discussions with various developers in the State of Florida to determine the best strategic location and partners for the company to establish its research facilities. Sites presently being considered are world-class research and technology parks, which will allow Regenicin to collaborate with leading centers of excellence in the academic, research, and healthcare arenas.

The company is pursuing opportunities to lease new facilities that will not only accommodate the company's present needs for state-of-the-art lab space, but will also address the projected growth needs the company envisions as it executes its business plan.

The State of Florida is an exciting new destination for Regenicin and it offers many appealing amenities with logistical and financial considerations for the biotech and life sciences industries. We hope to be able to announce our site selection in the near future.

Safe Harbor

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including, without limitation, the future press releases of Regenicin, Inc.


Contact:
Randall McCoy
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES